Exhibit 10.3
MEMORANDUM OF UNDERSTANDING
The following describes the understanding of both GEOMC Co. Ltd ("GEOMC") and
Competitive Technologies, Inc. ("CTT") regarding the revenue splits for sales of Calmare
Therapy MC-5A Unit.
1. GEOMC will receive $[Confidential Information Omitted] for the sale of each unit.
2. Samples will be shipped at a cost of $[Confidential Information Omitted]/unit and the cost will be shared equally between GEOMC and CTT.
These splits will be reviewed periodically and adjusted when appropriate.
//s//
//s//
John B. Nano
Young H. Lim
President & CEO
President & CEO
Competitive Technologies, Inc.
GEOMC Co., Ltd.
1/14/10
1/18/10
Date
Date
*Confidential information on this page has been omitted Pursuant to Rule 24b-2,
and has been filed separately with the Securities and Exchange Commission*
CTTC8K3411014